CTX-009
CTX-009-003
Phase 2 small_molecule completed
Quick answer
CTX-009 for Metastatic Colorectal Cancer is a Phase 2 program (small_molecule) at Compass Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Compass Therapeutics
- Indication
- Metastatic Colorectal Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed